Profound Medical Corp.

PROF Nasdaq CIK: 0001628808

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation Ontario, Canada
Business Address 2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, A6, L4W 5K5
Mailing Address 2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, A6, L4W 5K5
Phone 647-476-1350
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025 FY

$16.10M
Revenue
-$27.82M
Net Income
$77.47M
Total Assets
$11.04M
Total Liabilities
$66.43M
Stockholders' Equity
$59.72M
Cash & Equivalents
$1.41
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events April 1, 2026 View on SEC
8-K Current report of material events March 27, 2026 View on SEC
8-K Current report of material events March 13, 2026 View on SEC
8-K Current report of material events March 10, 2026 View on SEC
8-K Current report of material events March 9, 2026 View on SEC
8-K Current report of material events March 5, 2026 View on SEC
10-K Annual financial report March 5, 2026 View on SEC
8-K Current report of material events February 12, 2026 View on SEC
8-K Current report of material events February 12, 2026 View on SEC
8-K Current report of material events February 5, 2026 View on SEC

Annual Reports

10-K March 5, 2026
  • Pioneering incision-free treatment solutions using AI-powered, real-time MRI-guided systems for precise tissue destruction.
  • Flagship TULSA-PRO system is FDA, CE Mark, and Health Canada approved for prostate cancer and BPH, aiming to reduce side effects.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.